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Abstract
Background: Considering the broad variation in the expression of housekeeping genes among
tissues and experimental situations, studies using quantitative RT-PCR require strict definition of
adequate endogenous controls. For glioblastoma, the most common type of tumor in the central
nervous system, there was no previous report regarding this issue.
Results: Here we show that amongst seven frequently used housekeeping genes TBP and HPRT1
are adequate references for glioblastoma gene expression analysis. Evaluation of the expression
levels of 12 target genes utilizing different endogenous controls revealed that the normalization
method applied might introduce errors in the estimation of relative quantities. Genes presenting
expression levels which do not significantly differ between tumor and normal tissues can be
considered either increased or decreased if unsuitable reference genes are applied. Most
importantly, genes showing significant differences in expression levels between tumor and normal
tissues can be missed. We also demonstrated that the Holliday Junction Recognizing Protein, a
novel DNA repair protein over expressed in lung cancer, is extremely over-expressed in
glioblastoma, with a median change of about 134 fold.
Conclusion: Altogether, our data show the relevance of previous validation of candidate control
genes for each experimental model and indicate TBP plus HPRT1 as suitable references for studies
on glioblastoma gene expression.
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Background
Methods for the quantification of accurate gene expres-
sion have an increasingly important role in studies aiming
for the reliable examination of expression profiles gener-
ated by high-throughput approaches. Real-time reverse
transcription quantitative PCR (qRT-PCR) has emerged as
one of the most powerful tools for this purpose. Given the
extreme sensitivity of qRT-PCR, a careful and stringent
selection of a proper constitutively expressed control gene
is required to account for differences in the amount and
quality of starting RNA and in cDNA synthesis efficiency.
Adequate normalizations presume the use of an internal
control, often referred to as a housekeeping or reference
gene, whose expression levels should not significantly
vary among tissues and experimental situations analyzed
[1,2]. Genes most commonly applied as references in
qRT-PCR studies include: beta actin (ACTB), glyceral-
deyde-3-phosphate dehydrogenase (GAPDH), beta glu-
curonidase (GUSB), hypoxanthine guanine
phosphoribosyl transferase (HPRT1) and ribosome small
subunit (18S) ribosomal RNA [1-3]. However, several
reports have mentioned these classical housekeeping
genes as showing variable expression levels in different
experimental conditions [3-9]. Furthermore, the same
gene revealed as almost invariant for certain tissues or cell
types or could present highly variable expression levels in
other tissues or experimental conditions [2,9,10]. Thus, it
is clear that suitable control genes are extremely specific
for particular sample sets and experimental models, being
a crucial component in assessing confident gene expres-
sion patterns. It has been strongly suggested that more
than one stable expressed reference gene should be used
to avoid misinterpretation of gene expression data
[6,7,11-13].
In this context, the present work aimed to evaluate suita-
bility of selected candidate housekeeping genes for expres-
sion analysis in glioblastoma (GBM), the highest-grade
malignant astrocytoma [14]. These malignant gliomas are
the most common and the major lethal type of tumor in
the central nervous system [15], leading to a mean sur-
vival time of 1 year after diagnosis [16]. This discouraging
prognosis is decurrent from both the infiltrative nature of
the tumor and the resistance of tumor cells to cytotoxic
treatments [17-19]. Many therapy modalities based on
characterized genetic alterations are already in use or in
clinical trials phase, but their efficacy is still below expec-
tation [19-21]. Thus, the need for novel therapeutic targets
for GBM treatment becomes urgent. In this direction, sev-
eral recent studies are dedicated to explore high-through-
put expression profiles, using qRT-PCR to produce
reliable measurements, in order to identify novel genes
differentially expressed in GBM [22-26].
Although the necessity of stringent selection of house-
keeping genes is well established, until now it has been no
systematic investigation directed to point out adequate
control genes for quantitative expression analysis in GBM.
The majority of the studies apply one of the most com-
monly used housekeeping genes, such as ACTB  and
GAPDH. To get the actual panorama of reference genes
used in GBM quantitative expression studies, we per-
formed a Medline search using the terms real-time PCR
and glioma. We found 45 available articles, published
from January 2007 to July 2008, based on the use of dif-
ferent reference genes. More than 80% of these studies use
one of the following genes as internal controls: ACTB
(cited 19 times, 42%), GADPH (cited 13 times, 29%) or
18S rRNA (cited 5 times, 11%), without any previous
evaluation of their stability within the model. This search
revealed that we do not have a consensus in the field and,
moreover, a meaningful study on the application of refer-
ence genes in glioblastoma gene expression investigation
is essential and timely.
Therefore, we investigated here the suitability of seven fre-
quently used housekeeping genes for real-time RT-PCR
analysis in human GBM versus non-neoplastic white mat-
ter comparisons. We determined that TBP and HPRT1 are
suitable reference genes for expression studies in GBM.
The significance of applying adequate normalization
methods was demonstrated by the evaluation of the
expression levels of 12 target genes upon different nor-
malization approaches. Our data revealed that, depend-
ing on the normalization method utilized, genes whose
expression levels are similar in normal and tumor tissues
could be interpreted as up or down regulated and genes
presenting significant differences in expression levels can
be missed. These data show the relevance of previous val-
idation of candidate control genes to obtain adequate
normalizations in quantitative expression studies.
Results
The Expression Levels of Candidate Housekeeping Genes
We chose to investigate seven housekeeping genes com-
monly used as internal controls in expression studies,
ACTB, GAPDH, GUSB, HMBS, HPRT1, TBP and 18S rRNA
(Table 1). According to articles published over the past
two years, three of them, ACTB, GAPDH and 18S rRNA,
collectively correspond to the endogenous controls
applied in more than 80% of expression analyses per-
formed on glioma tumors or cell lines. Transcriptional
levels of the seven selected genes were determined in a
panel of 39 microdissected samples from different indi-
viduals, nine non-neoplastic white matter and 30 gliob-
lastomas, using real-time RT-PCR. For comparison of
housekeeping transcription levels, the cycle threshold
(CT) values were plotted directly, assuming the same
threshold for all genes evaluated. The CT is defined as the
number of cycles needed for fluorescence to reach a spe-
cific threshold level of detection and is inversely corre-
lated with the amount of RNA template present in theBMC Molecular Biology 2009, 10:17 http://www.biomedcentral.com/1471-2199/10/17
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reaction. The seven housekeeping genes analyzed here dis-
played a wide expression range, with CT values between 14
and 32 (figure 1). The CT values for all these genes showed
normal distribution according to the Kolmogorov and
Smirnov method, in both tumor and non-neoplastic sam-
ples. These genes are clearly distributed into different
expression level categories. The extremely abundant 18S
rRNA, which represents the bulk of total RNA in the cell,
presented CT values below 18 cycles; genes coding for
highly expressed mRNAs, such as ACTB and GAPDH, with
majority of CT values between 18 and 22 cycles; and the
moderately expressed genes, GUSB, HMBS, HPRT1 and
TBP, showing CT values between 26 and 30 cycles. We also
noted slightly higher levels in the abundance of GUSB and
HPRT1 mRNAs than in HMBS and TBP mRNAs. For all
candidate control genes analyzed, the amplitudes in
expression ranges were of about 3–4 cycles larger in GBM
than in non-neoplastic samples (figure 1), pointing out
the great variability in gene expression levels peculiar of
heterogeneous cancer tissues even for those so called
housekeeping genes.
Stability of Candidate Housekeeping Genes on Normal 
and Neoplastic Brain Tissues
Our main objective was to identify housekeeping genes
with minimal variability among our set of samples, which
includes non-neoplastic white matter and glioblastoma
tumors. In order to determine the least variable reference
genes, we evaluated expression stability of the seven can-
didate controls in our panel of samples, by the geNorm
software analysis. GeNorm calculates a gene-stability
measure (M) based on the average pairwise variation
between a particular gene and all other genes studied.
High expression stability is indicated by a low M value as
an estimate of combined variation of the individual gene.
Successive elimination of the least stable gene ranks the
candidate housekeeping genes according to their M values
and identifies the two most stable reference genes [13].
The M values calculated by geNorm for the seven candi-
date endogenous controls are shown in table 2. All ana-
lyzed genes reached M values below the default limit of
1.5 suggested in the geNorm program. After stepwise
exclusion of the least stable genes from bottom to top,
ACTB and GUSB were found to be the two most stable ref-
erence genes, with paired M equal to 0.56, followed by
TBP with M equal to 0.736.
However, if we compared raw CT values of tumor versus
non-neoplastic samples, as suggested by Ohl F. and col-
laborators (2005), significant differences in gene expres-
sion between GBM and normal white matter were found
for ACTB (Student's t test, P = 0,016), GAPDH (P = 0,006),
GUSB  (P = 0,005) and 18S rRNA (P = 0.012). ACTB,
GAPDH  and  GUSB  mRNA levels are significantly
increased in tumor samples, with changes of about 3.6,
3.5 and 4.7 fold, respectively; while 18S rRNA was
revealed to be slightly diminished in tumor samples, in a
proportion of approximately 13% (figure 2). The encoun-
tered differences reveal that ACTB, GAPDH, GUSB and
18S rRNA are inadequate control genes for normalization
purposes in profiling studies comparing GBM to the nor-
mal counterpart. These four genes were consequently
excluded from geNorm analysis and the three candidate
controls whose expression levels did not significantly vary
between normal and tumor tissues (HMBS, HPRT1 and
TBP) were reevaluated by the geNorm software. The M val-
ues calculated by geNorm for these three endogenous con-
trol candidates are 1.423, 1.247 and 1.047 for HMBS,
HPRT1 and TBP, respectively. Thus, TBP and HPRT1 were
indicated by geNorm as the two most suitable reference
genes, presenting a combined M value of 0.871, much
lower than the 1.5 suggested cut off (table 3).
Expression stability of HMBS, HPRT1 and TBP genes were
additionally evaluated with NormFinder, other software
that uses a model-based approach to measure gene expres-
sion variation among sample subgroups [27].
NormFinder calculates stability values for each analyzed
gene on the basis of inter- and intragroup expression var-
iation. The lower stability values indicate the more stable
expressed candidate genes. Although this analysis
revealed that TBP and HMBS show the lower isolated sta-
bility values, NormFinder also indicates TBP and HPRT1
as the best combination of two genes for normalizing cal-
culations, with a combined gene stability value of 0.166
(table 3). We also performed the equivalence test [28] to
Expression levels of candidate housekeeping genes in gliob- lastoma and non-neoplastic white matter Figure 1
Expression levels of candidate housekeeping genes in 
glioblastoma and non-neoplastic white matter. Boxes 
represent lower and upper quartiles of cycle thresholds 
range with medians indicated, whiskers represent the 10th 
and 90th percentiles. Black boxes correspond to non-neoplas-
tic white matter samples and hatched boxes to tumor sam-
ples. Graph was plotted with Sigma Plot 10.0 software.
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estimate the significance of differences in the median
expression values between tumor and normal tissues of
each individual gene. We observed that among all genes
studied  TBP  and  HPRT1  were confirmed as the more
equivalently expressed, once the confidence intervals they
presented are included in deviation area and are closest to
zero (figure 3). Therefore, it can be concluded that nor-
malization using these two reference genes is an adequate
approach for gene expression studies in GBM.
Evaluation of the Expression Profiles of Target Genes 
Following Different Normalization Approaches
We have performed different normalization approaches
to a set of target genes to demonstrate the importance of
using suitable housekeeping genes in order to get the cor-
rect expression profiles. Based on data from a previously
analyzed microarray [26], we selected 12 target genes, can-
didates of being over-expressed in GBM, for quantitative
RT-PCR experiments to investigate reliability of over-
expression suggestion. According to microarray data,
these 12 selected genes presented changes of tumor versus
normal expression levels higher than 25 fold and, at the
beginning of this study they had no molecular characteri-
zation, being classified as unknown function after Gene
Ontology analysis. Thus, this set of genes represented
putative novel genes involved in GBM development.
Table 4 gives identification of the 12 analyzed target genes
and summarizes their current annotation status [29-38].
Expression levels of these target genes were determined in
our panel of glioblastoma and non-neoplastic white mat-
ter samples. Normalization was performed using five dif-
ferent methods: with normalization factors calculated by
geNorm considering TBP plus HPRT1 as references, with
TBP and HPRT1 separately, and with the two unstable
genes, GUSB and 18S rRNA, which are 4.7 fold increased
and 13% decreased, respectively, in GBM when compared
to normal white matter. In general, expression levels of
target genes in GBM and normal white matter when using
TBP plus HPRT1, or either TBP or HPRT1 alone show sim-
ilar pattern, but in several cases the significance of differ-
ences vary (see additional file 1), demonstrating that the
simultaneous use of two adequate reference genes is indi-
cated. If we compare the expression profiles obtained with
the most confident normalization approach
(TBP+HPRT1) to the expression profiles given by using
either GUSB or 18S RNA, we will observe dramatic differ-
ences (figure 4). Among seven genes whose expression
levels did not significantly vary between tumor and nor-
mal tissues, five (71%) would be considered significantly
diminished when normalized with GUSB (figure 4B, G, I,
Table 1: Selected housekeeping genes for expression analysis
Gene name Gene symbol Accession number Function
Beta-actin ACTB NM_001101 Cytoskeletal structural protein
Glyceraldeyde-3-phosphate dehydrogenase GAPDH NM_002046 Glycolysis enzyme
Beta-glucuronidase GUSB NM_000181 Exoglycosidase in lysosomes
Hydroxymethylbilane synthase HMBS NM_000190 Heme biosynthetic pathway
Hypoxanthine guanine phosphoribosyl transferase 1 HPRT1 NM_000194 Metabolic salvage of purines
TATA-box binding protein TBP NM_003194 General transcription factor
18S ribosomal RNA rRNA NR_003286 Ribosome subunit
Table 2: Expression stability measures (M) calculated by geNorm 
for all candidate housekeeping genes analyzed
Ranking order Gene M values1
1 ACTB 0.603
2 GUSB 0.693
3 TBP 0.736
4 GAPDH 0.918
5 HPRT1 1.049
6 18S rRNA 1.277
7 HMBS 1.344
Best combination of two genes ACTB + GUSB 0.560
1 Lower M values indicate higher expression stability
Expression levels fold changes of candidate housekeeping  genes in tumor versus normal tissues Figure 2
Expression levels fold changes of candidate house-
keeping genes in tumor versus normal tissues. Bars 
show the ratios of median expression levels between tumor 
and normal tissues for the indicated housekeeping genes. 
Asterisks indicate the significance of differences, * P values < 
0.05 and ** P values < 0,005. Graph was plotted with Sigma 
Plot 10.0 software.
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J and 4K) and six (86%) would be considered significantly
increased when normalized with 18S rRNA (figure 4B, E,
G, I, J and 4K). Additionally, the two genes that indeed
showed higher quantities in GBM could not be detected
when normalized with GUSB or could have an overesti-
mated increase when normalized with 18S rRNA (figure
4A and 4L). Similar misinterpretation could occur in the
case of the two genes presenting lower quantities in GBM,
which would be considered as not significantly differing
or could have an overestimated decrease, when normal-
ized with either 18S rRNA or GUSB, respectively (figure
4D and 4F). The normalization method applied did not
significantly alter only the expression profile of
NM_018410 (TG8), whose mRNA quantities are enor-
mously higher in tumor than in normal tissue (figure 4H,
note that the graph is presented in logarithmic scale).
Despite that, even in this case, we observed different ratios
of expression level when normalizing with TBP+HPRT1
(134 fold), GUSB (52 fold) or 18S rRNA (340 fold). As
our data has shown, among 12 genes analyzed, 10 (83%)
presented different expression profiles depending on the
normalization approach utilized. These data reveal that
the use of inadequate endogenous control could have a
significant impact on the evaluation of target gene expres-
sion levels, in many cases giving contrary results, espe-
cially for those presenting small differences between
tumor and normal tissue.
Discussion
The present study is the first report of a systematic evalua-
tion of potential reference genes with regard to their use-
fulness as normalizers in malignant glioma expression
studies. Amongst seven commonly used classical house-
keeping genes, we found that expression levels of ACTB,
GAPDH,  GUSB  and  18S rRNA, significantly differed
between tumor and normal tissues on the basis of the
examination of raw CT values (figure 2). It could be con-
cluded that these genes are regulated and thus not indi-
cated for target gene normalizations. It was previously
reported that this initial analysis is mandatory in order to
exclude highly unstable genes from further calculations
using programs based on pairwise variation, such as
geNorm and NormFinder [7,39]. In those studies, Ohl
and collaborators have found genes up and down regu-
lated in prostate and bladder cancer samples through
comparisons of CT values. We also consider this prelimi-
nary exclusion crucial, because the simultaneous analysis
of several genes whose expression levels are similarly
biased, could lead to the wrong choice on the basis of soft-
ware evaluation only. This type of misinterpretation can
be clearly illustrated by data presented in table 2, where
ACTB and GUSB are being indicated as the two best refer-
ence genes. ACTB and GUSB selection, based on geNorm
analysis including the seven potential housekeeping
genes, probably resulted from similarities in the expres-
sion pattern of these two genes, which are both signifi-
cantly up regulated in tumor tissues, as well as GAPDH
(figure 2). Although such genes that regulate basic and
ubiquitous cellular functions are frequently assumed as
almost invariable between different samples, many other
studies corroborate our observations and have also dem-
Table 3: Expression stability values calculated by geNorm and NormFinder for the three genes expressed in similar levels between 
tumor and normal tissues
Gene geNorm NormFinder
HMBS 1.344 0.298
HPRT1 1.049 0.356
TBP 0.736 0.164
Best combination of two genes TBP + HPRT1 = 0.87 TBP + HPRT1 = 0.166
Equivalence test for the seven candidate housekeeping genes  in the white matter and GBM sample groups Figure 3
Equivalence test for the seven candidate housekeep-
ing genes in the white matter and GBM sample 
groups. The differences of means (solid circles) and the 
matching symmetrical confidence intervals (whiskers) are 
shown for the logarithmized relative expression of each ref-
erence gene. Y-axis represents the fold changes in expres-
sion levels between tumor and normal tissues. The deviation 
area from -1 to 1 indicates fold changes ≤ 2. If the symmetri-
cal confidence interval is included in the deviation area and 
contains zero, the gene is considered equivalently expressed.
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Expression levels of target genes in normal and tumor tissues upon different normalization approaches Figure 4
Expression levels of target genes in normal and tumor tissues upon different normalization approaches. Median 
relative quantities of target genes (TG1–12) in non-neoplastic white matter (black bars) and glioblastoma (gray bars) samples 
were plotted after normalization under the indicated conditions: with geNorm normalization factors calculated from TBP plus 
HPRT1 and with the genes GUSB or 18S rRNA alone. Whiskers indicate the standard deviation. Significance between differences 
was calculated by the use of Mann-Whitney test. Asterisks indicate the significance of differences, * P values < 0.05 and ** P val-
ues < 0,005. Graphs were plotted with Sigma Plot 10.0 software.
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onstrated that their individual expression may vary as a
result of neoplastic growth, hypoxia or experimental treat-
ment [1,3,5,6,11]. These data show the obligatory require-
ment of prior exclusion of regulated genes based on raw
expression data evaluation.
Among the seven candidate housekeeping genes ana-
lyzed, TBP and HPRT1 were indicated as the best combi-
nation of reference genes for expression studies in GBM,
using three independent methods of analysis: geNorm
[13], NormFinder [27] and equivalence test [28].
Recently, both HPRT1 and TBP were indicated as suitable
reference genes for differential expression studies using
qRT-PCR in different type of cancers, moreover HPRT1
was recommended as a universal single reference gene for
expression analysis in cancer [3,7,39]. However, normali-
zations based in more than one best-performing reference
gene gives more accurate results and has been increasingly
suggested [6,13,40]. In our study, we observed differences
in the significance of comparisons when utilizing TBP and
HPRT1 associated or each one separately (see additional
file 1). Thus, until further extended analysis becomes
available, we suggest the use of TBP plus HPRT1 as the
more adequate endogenous controls for target gene nor-
malizations in GBM expression analysis.
The significance of applying different reference genes for
the estimation of the relative quantities of gene expres-
sion, was demonstrated here by the analysis of 12 target
genes, candidates of being over expressed in GBM, follow-
ing three normalization approaches: i) with geNorm nor-
malization factors calculated for TBP+HPRT1; ii) with
GUSB, which is ~4.7 times increased in tumors; and iii)
with 18S rRNA, which is ~13% decreased in GBM sam-
ples. Our data clearly show that the normalization
method applied might introduce errors in the estimation
of relative expression levels. Genes, whose expression lev-
els did not significantly vary between tumor and normal
tissues, would be considered significantly diminished
when normalized with GUSB or increased when normal-
ized with 18S rRNA. Moreover, genes presenting signifi-
cant differences in the relative quantities between tumor
and normal tissues can be missed if these unsuitable
endogenous controls are utilized (figure 4). Therefore, we
can conclude that for GBM gene expression studies, GUSB
along with the most frequently utilized internal controls,
ACTB and GAPDH, must be considered inadequate for
normalizations due to its significant increase in tumor
samples. 18S rRNA also led to erroneous estimation in
gene expression levels and proved not to be useful for nor-
malizations. This could be explained by the imbalance
between messenger and ribosomal RNA [41] or, possibly,
by the independently regulated rRNA transcription, which
is carried out by RNA polymerase I, as previously reported
[1].
In this study, we found five genes whose expression levels
significantly differ between tumor and normal samples.
Surprisingly, two of them were decreased (TG4 and TG6)
and three (TG1, TG8 and TG12) were increased in tumor
tissue, and only one confirmed the high expression levels
(>25 fold) indicated by the microarray data [26]. This is
probably due to the difference in the sizes of the tumor
samples analyzed that was five times smaller in the micro-
array experiments (n = 6) than in the qRT-PCR analysis
performed here (n = 30). We also observed that the vali-
dation rate of the microarray data obtained in our study
(25%) was much lower than previously reported (90%)
[26]. The high validation rate reported in the former study
can be explained by the criteria of target genes selection,
which was biased to genes related to pathways probably
altered in cancer. One of the three genes validated here,
NM_018410, presents transcription levels extremely ele-
vated in GBM, independently of the reference gene uti-
lized (TG8, figure 3H). Over-expression of TG8 in GBM
when compared to pilocytic astrocytoma was previously
Table 4: Target genes evaluated in expression analysis
Code Accession number Gene symbol Functional/domain information Reference
TG1 NM_001080522 CC2D2A coiled-coil and C2 domain containing 2A Noor A et al., 2008 [29]
TG2 NM_017925 DENND4C DENN/MADD domain containing 4C Olsen JV et al., 2006 [30]
TG3 NM_024759 NPAL2 NIPA-like domain containing 2 Lefrève, C et al., 2004 [31]
TG4 NM_022831 AIDA axin interactor, dorsalization associated Rui Y et al., 2007 [32]
TG5 NM_024857 ATAD5 ATPase family, AAA domain containing 5 Douglas, J et al., 2007 [33]
TG6 NM_024859 MAGIX MAGI family member, X-linked transcript variant 1 Ota T et al., 2004 [34]
TG7 NM_018093 WDR74 WD repeat domain 74 Eilbracht J et al., 2004 [35]
TG8 NM_018410 HJURP Holliday junction recognition protein Kato T et al., 2007 [36]
TG9 NM_152622 MIER3 mesoderm induction early response 1, family member 3 Mehrle A et al., 2006 [37]
TG10 NM_024942 C10 or f88 chromosome 10 open reading frame 88 Gerhard, DS et al., 2004 [38]
TG11 NM_138341 TMEM116 transmembrane protein 116 Gerhard, DS et al., 2004 [38]
TG12 NM_018087 TMEM48 transmembrane protein 48 Olsen JV et al., 2006 [30]BMC Molecular Biology 2009, 10:17 http://www.biomedcentral.com/1471-2199/10/17
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suggested by microarray data analysis, where a change of
about nine fold was observed [42]. This gene was recently
annotated as HJURP, the Holliday Junction Recognition Pro-
tein. It was demonstrated that HJURP is over expressed in
lung cancer and is involved in chromosomal stability,
being a competence factor for immortality of cancer cells
in culture [36]. The role of HJURP in glioblastoma will be
further characterized.
Conclusion
In conclusion, our data show the relevance of previous
validation of candidate housekeeping genes for each spe-
cific application, especially when small differences are
intended to be detected. For glioblastoma, it was demon-
strated that TBP plus HPRT1 are suitable reference genes
for normalization purposes in gene expression profiling
studies. Together, these results highlight the importance
of careful reevaluation of glioblastoma gene expression
data currently available.
Methods
Tissue samples
Glioblastoma samples were obtained from 30 patients
(mean age 55 years, range 19–79 years) submitted to sur-
gical resection for tumor ablation at the Clinical Hospital
of the Faculty of Medicine of Ribeirão Preto, University of
São Paulo. Tumor grade was determined according to
WHO criteria [14]. Non-neoplastic white matter samples
were obtained from patients undergoing temporal lobec-
tomy for epilepsy treatment. The study was approved by
the Ethics Committee of the Faculty of Medicine and
informed consent was obtained from each patient. Thirty
tumors and nine non-neoplastic fresh surgical samples
were sectioned and immediately snap-frozen in liquid
nitrogen upon surgical removal. All tissue samples were
microdissected for exclusion of tissue areas presenting
necrosis or not matching to GBM diagnostic prior to RNA
extraction. Standardized conditions of storage and micro-
dissection of tumor samples are important steps to guar-
antee reliability of data and the conclusions derived from
them, since GBM are heterogeneous solid tumors often
presenting necrosis [16].
RNA Isolation and Quality Evaluation
Total RNA was isolated using the TRIzol Reagent (Invitro-
gen) following the manufacturer's instructions with an
additional phenol/clorophorm extraction to improve pro-
tein exclusion. The concentration and purity of isolated
RNA were assessed by absorbance (A) readings on a UV
spectrophotometer (Hitachi) at the wavelengths of 260
and 280 nm. The mean ratio value of A260/280 for all RNA
samples was 1.81 (± 0.06), reflecting high purity and pro-
tein absence. RNA integrity was evaluated by the ratio of
28S/18S ribosomal RNA bands after eletrophoresis in
denaturing 1% agarose gel. To guarantee the quality nec-
essary for expression analysis all samples used in this
study presented a 28S/18S rRNA ratio ≥1.7.
DNAse Treatment and cDNA synthesis
One microgram of total RNA from each sample was
treated with DNAse I enzyme (Invitrogen) in the presence
of 40 U of RNAse inhibitor (RNAseOUT, Invitrogen), fol-
lowing the instructions of the manufacturer. Treated RNA
was reverse transcribed using the HighCapacity kit
(Applied Biosystems) in 20 μL of final volume, according
to fabricant's recommendations and with addition of 250
ng of oligo(dT)18–24 per reaction.
Quantitative Real-Time RT-PCR
All primers were designed with OligoExplorer 1.2 soft-
ware to amplify at 60°C and to bind specifically to differ-
ent exons of human cDNA sequences. To evaluate the
possibility of genomic amplification, minus-RT PCR were
performed using DNAse treated RNA in the same dilution
used for the cDNA samples. No amplification of the
expected products were detected, except for the genes 18S
rRNA, which does not have introns, and ACTB, that
presents pseudogene in the genome. However, the relative
quantities obtained in minus-RT reactions were at least
three orders of magnitude lower than in qRT-PCR per-
formed with cDNA samples. Moreover, the amplification
products were detected in similar levels in both GBM and
normal white matter (control) samples. Primer
sequences, the GenBank Accession numbers of target
cDNAs, as well as the amplification reaction information
are shown in table 5. The relative mRNA expression levels
of target genes and candidate housekeeping genes were
quantified using real-time PCR analysis with a Gene Amp®
7500 Sequence Detection System (PE Applied Biosys-
tems).
Amplification of specific PCR products was detected using
the SYBR Green PCR Master Mix (PE Applied Biosystems)
according to the manufacturer's protocol. All primers
employed were synthesized by MWG Biotech Inc or Invit-
rogen. Amplification efficiency of each primer pair was
evaluated by the standard curve method using serial dilu-
tions of pooled cDNA. All primer pairs utilized in this
study presented amplification efficiency between 87–
110% (table 5). Reactions without template were run in
parallel for all plates to verify purity of measurements
within each experiment. Each run was completed with a
melting curve analysis to confirm the specificity of ampli-
fication and lack of primer dimers. The 2-ΔΔCT equation
[43] was applied to calculate the relative expression of
tumor samples and non-neoplasic brain tissues. Mean CT
of non-neoplastic brain tissues was used as the calibrator
sample.BMC Molecular Biology 2009, 10:17 http://www.biomedcentral.com/1471-2199/10/17
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Statistical data analysis
The normality test was performed by the Kolmogorov and
Smirnov method and significance between differences in
mean CT values was measured by unpaired test t, using
GraphPad InStat software. The differences in gene expres-
sion levels were analyzed by the Mann-Withney test, using
the SPSS 15.0 software. P values < 0.05 were considered
statistically significant. For evaluation of expression sta-
bility of the candidate reference genes, we applied the soft-
wares geNorm [13] and NormFinder [27], and the
equivalence test [28], as previously described. The
geNorm and NormFinder programs are Visual Basic appli-
cation tools for Microsoft Excel available on internet upon
request to developers. CT values were converted into raw
relative quantities considering the PCR efficiency 2.
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Table 5: Primer sequences and amplification summary
Gene Primer Sequence [5' → 3'] Amplicon size (bp) Intervening sequence size (bp) Amplification efficiency (%)
ACTB F: GGCACCCAGCACAATGAAG
R: CCGATCCACACGGAGTACTTG
66 178 98
GAPDH F: AGATCCCTCCAAAATCAAGTGG
R: GGCAGAGATGATGACCCTTTT
130 220 98
GUSB F: GAAAATATGTGGTTGGAGAGCTCATT
R: CCGAGTGAAGATCCCCTTTTTA
101 3360 93
HMBS F: CACGATCCCGAGACTCTGCT
R: TACTGGCACACTGCAGCCTC
81 315 104
HPRT1 F: TGAGGATTTGGAAAGGGTGT
R: GAGCACACAGAGGGCTACAA
118 1833 99
TBP F: GAGCTGTGATGTGAAGTTTCC
R: TCTGGGTTTGATCATTCTGTAG
117 1747 110
18S rRNA F: GGAGTATGGTTGCAAAGCTGA
R: ATCTGTCAATCCTGTCCGTGT
129 _ 89
TG1 F: AAGGTCGGAAGAAGGTGACAG
R: GCTGCTGGAATTTGCTCACTG
120 4217 97
TG2 F: CTTTACCCAGCGACCGTTTCA
R: GGACTCAAGTAGGGCACAGAA
123 2206 96
TG3 F: TACTCTGATCGCTCCGTTAGG
R: CCTGCAAATGCCAGTGTCGTA
120 29982 92
TG4 F: AAAGATGCTGGGCAGTGCATC
R: CCACAGGAGTATCTTGCACAG
94 2754 90
TG5 F: GCCAACCCTTCGAAACATCTG
R: AGCTGCCAAAGTATTCACAGTC
130 242 110
TG6 F: AGCGCTGTGGTCGTTTGGAG
R: GACGAATAACCAGGTGGAGCT
132 231 101
TG7 F: TTGCCACAGGTGGGAAAGAGA
R: CAGTCATTCCGCACGTTCTTG
94 256 99
TG8 F: GAAGGGATGTACGTGTGACTC
R: CCATTCTCTGGGAGATGAAGC
131 2129 98
TG9 F: GCCGAAGCTTTGAACATGCAC
R: CACACTCAGCAACTGTCCTAG
93 4817 110
TG10 F: CTCTCCTGCTCTAGGATCAAG
R: ATTCCGCTGCTGACACCTAAC
124 3241 96
TG11 F: GAACAGTGGGCAGTGATTCAC
R: TTGGTGTCCTGTGGCTTAGTC
125 1351 87
TG12 F: CGGATTTCAGGAAGCCTTGTG
R: GCAGATGCTTGCACAGCATTC
131 4426 90
F: forward primer, R: reverse primerBMC Molecular Biology 2009, 10:17 http://www.biomedcentral.com/1471-2199/10/17
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